Onset of Clinical Response with Deucravacitinib in Patients with Moderate to Severe Scalp Psoriasis: A Post Hoc Analysis of the Phase 3b/4 PSORIATYK SCALP Trial. J of Skin [Internet]. 2025 Mar. 17 [cited 2025 May 20];9(2):s539. Available from: https://skin.dermsquared.com/skin/article/view/3323